Global Prostate Cancer Vaccines Market Growth 2020-2025
According to this study, over the next five years the Prostate Cancer Vaccines market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Prostate Cancer Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Cancer Vaccines market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Prostate Cancer Vaccines, covering the supply chain analysis, impact assessment to the Prostate Cancer Vaccines market size growth rate in several scenarios, and the measures to be undertaken by Prostate Cancer Vaccines companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Tablet
Injection
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Dendreon Corporation
Pfizer Inc.
Bavarian Nordic
OncBioMune Pharmaceuticals
Advaxis immunotherapies
Advantagene
Curevac AG
SOTIO
Mediolanum Farmaceutici
Cleveland BioLabs Inc.
UbiVac
Vaccibody AS
Momotaro-Gene Inc.
Vaccitech
Ultimovacs
Medigene AG
Oncovir Inc.
Sensei Biotherapeutics
AlphaVax Inc.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Prostate Cancer Vaccines consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Prostate Cancer Vaccines market by identifying its various subsegments.
Focuses on the key global Prostate Cancer Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Prostate Cancer Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Prostate Cancer Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prostate Cancer Vaccines Consumption 2015-2025
2.1.2 Prostate Cancer Vaccines Consumption CAGR by Region
2.2 Prostate Cancer Vaccines Segment by Type
2.2.1 Tablet
2.2.2 Injection
2.3 Prostate Cancer Vaccines Consumption by Type
2.3.1 Global Prostate Cancer Vaccines Consumption Market Share by Type (2015-2020)
2.3.2 Global Prostate Cancer Vaccines Revenue and Market Share by Type (2015-2020)
2.3.3 Global Prostate Cancer Vaccines Sale Price by Type (2015-2020)
2.4 Prostate Cancer Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Prostate Cancer Vaccines Consumption by Application
2.5.1 Global Prostate Cancer Vaccines Consumption Market Share by Type (2015-2020)
2.5.2 Global Prostate Cancer Vaccines Value and Market Share by Type (2015-2020)
2.5.3 Global Prostate Cancer Vaccines Sale Price by Type (2015-2020)
3 Global Prostate Cancer Vaccines by Company
3.1 Global Prostate Cancer Vaccines Sales Market Share by Company
3.1.1 Global Prostate Cancer Vaccines Sales by Company (2018-2020)
3.1.2 Global Prostate Cancer Vaccines Sales Market Share by Company (2018-2020)
3.2 Global Prostate Cancer Vaccines Revenue Market Share by Company
3.2.1 Global Prostate Cancer Vaccines Revenue by Company (2018-2020)
3.2.2 Global Prostate Cancer Vaccines Revenue Market Share by Company (2018-2020)
3.3 Global Prostate Cancer Vaccines Sale Price by Company
3.4 Global Prostate Cancer Vaccines Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Prostate Cancer Vaccines Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Prostate Cancer Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Prostate Cancer Vaccines by Regions
4.1 Prostate Cancer Vaccines by Regions
4.2 Americas Prostate Cancer Vaccines Consumption Growth
4.3 APAC Prostate Cancer Vaccines Consumption Growth
4.4 Europe Prostate Cancer Vaccines Consumption Growth
4.5 Middle East & Africa Prostate Cancer Vaccines Consumption Growth
5 Americas
5.1 Americas Prostate Cancer Vaccines Consumption by Countries
5.1.1 Americas Prostate Cancer Vaccines Consumption by Countries (2015-2020)
5.1.2 Americas Prostate Cancer Vaccines Value by Countries (2015-2020)
5.2 Americas Prostate Cancer Vaccines Consumption by Type
5.3 Americas Prostate Cancer Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Prostate Cancer Vaccines Consumption by Regions
6.1.1 APAC Prostate Cancer Vaccines Consumption by Regions (2015-2020)
6.1.2 APAC Prostate Cancer Vaccines Value by Regions (2015-2020)
6.2 APAC Prostate Cancer Vaccines Consumption by Type
6.3 APAC Prostate Cancer Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Prostate Cancer Vaccines by Countries
7.1.1 Europe Prostate Cancer Vaccines Consumption by Countries (2015-2020)
7.1.2 Europe Prostate Cancer Vaccines Value by Countries (2015-2020)
7.2 Europe Prostate Cancer Vaccines Consumption by Type
7.3 Europe Prostate Cancer Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Prostate Cancer Vaccines by Countries
8.1.1 Middle East & Africa Prostate Cancer Vaccines Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Prostate Cancer Vaccines Value by Countries (2015-2020)
8.2 Middle East & Africa Prostate Cancer Vaccines Consumption by Type
8.3 Middle East & Africa Prostate Cancer Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Prostate Cancer Vaccines Distributors
10.3 Prostate Cancer Vaccines Customer
11 Global Prostate Cancer Vaccines Market Forecast
11.1 Global Prostate Cancer Vaccines Consumption Forecast (2021-2025)
11.2 Global Prostate Cancer Vaccines Forecast by Regions
11.2.1 Global Prostate Cancer Vaccines Forecast by Regions (2021-2025)
11.2.2 Global Prostate Cancer Vaccines Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Prostate Cancer Vaccines Forecast by Type
11.8 Global Prostate Cancer Vaccines Forecast by Application
12 Key Players Analysis
12.1 Dendreon Corporation
12.1.1 Company Information
12.1.2 Prostate Cancer Vaccines Product Offered
12.1.3 Dendreon Corporation Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Dendreon Corporation Latest Developments
12.2 Pfizer Inc.
12.2.1 Company Information
12.2.2 Prostate Cancer Vaccines Product Offered
12.2.3 Pfizer Inc. Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Pfizer Inc. Latest Developments
12.3 Bavarian Nordic
12.3.1 Company Information
12.3.2 Prostate Cancer Vaccines Product Offered
12.3.3 Bavarian Nordic Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Bavarian Nordic Latest Developments
12.4 OncBioMune Pharmaceuticals
12.4.1 Company Information
12.4.2 Prostate Cancer Vaccines Product Offered
12.4.3 OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 OncBioMune Pharmaceuticals Latest Developments
12.5 Advaxis immunotherapies
12.5.1 Company Information
12.5.2 Prostate Cancer Vaccines Product Offered
12.5.3 Advaxis immunotherapies Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Advaxis immunotherapies Latest Developments
12.6 Advantagene
12.6.1 Company Information
12.6.2 Prostate Cancer Vaccines Product Offered
12.6.3 Advantagene Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Advantagene Latest Developments
12.7 Curevac AG
12.7.1 Company Information
12.7.2 Prostate Cancer Vaccines Product Offered
12.7.3 Curevac AG Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Curevac AG Latest Developments
12.8 SOTIO
12.8.1 Company Information
12.8.2 Prostate Cancer Vaccines Product Offered
12.8.3 SOTIO Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 SOTIO Latest Developments
12.9 Mediolanum Farmaceutici
12.9.1 Company Information
12.9.2 Prostate Cancer Vaccines Product Offered
12.9.3 Mediolanum Farmaceutici Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Mediolanum Farmaceutici Latest Developments
12.10 Cleveland BioLabs Inc.
12.10.1 Company Information
12.10.2 Prostate Cancer Vaccines Product Offered
12.10.3 Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Cleveland BioLabs Inc. Latest Developments
12.11 UbiVac
12.11.1 Company Information
12.11.2 Prostate Cancer Vaccines Product Offered
12.11.3 UbiVac Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 UbiVac Latest Developments
12.12 Vaccibody AS
12.12.1 Company Information
12.12.2 Prostate Cancer Vaccines Product Offered
12.12.3 Vaccibody AS Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Vaccibody AS Latest Developments
12.13 Momotaro-Gene Inc.
12.13.1 Company Information
12.13.2 Prostate Cancer Vaccines Product Offered
12.13.3 Momotaro-Gene Inc. Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Momotaro-Gene Inc. Latest Developments
12.14 Vaccitech
12.14.1 Company Information
12.14.2 Prostate Cancer Vaccines Product Offered
12.14.3 Vaccitech Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Vaccitech Latest Developments
12.15 Ultimovacs
12.15.1 Company Information
12.15.2 Prostate Cancer Vaccines Product Offered
12.15.3 Ultimovacs Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Ultimovacs Latest Developments
12.16 Medigene AG
12.16.1 Company Information
12.16.2 Prostate Cancer Vaccines Product Offered
12.16.3 Medigene AG Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Medigene AG Latest Developments
12.17 Oncovir Inc.
12.17.1 Company Information
12.17.2 Prostate Cancer Vaccines Product Offered
12.17.3 Oncovir Inc. Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Oncovir Inc. Latest Developments
12.18 Sensei Biotherapeutics
12.18.1 Company Information
12.18.2 Prostate Cancer Vaccines Product Offered
12.18.3 Sensei Biotherapeutics Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 Sensei Biotherapeutics Latest Developments
12.19 AlphaVax Inc.
12.19.1 Company Information
12.19.2 Prostate Cancer Vaccines Product Offered
12.19.3 AlphaVax Inc. Prostate Cancer Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 AlphaVax Inc. Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Prostate Cancer Vaccines Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Tablet
Table 5. Major Players of Injection
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Prostate Cancer Vaccines Consumption Market Share by Type (2015-2020)
Table 8. Global Prostate Cancer Vaccines Revenue by Type (2015-2020) ($ million)
Table 9. Global Prostate Cancer Vaccines Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Prostate Cancer Vaccines Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Prostate Cancer Vaccines Consumption Market Share by Application (2015-2020)
Table 13. Global Prostate Cancer Vaccines Value by Application (2015-2020)
Table 14. Global Prostate Cancer Vaccines Value Market Share by Application (2015-2020)
Table 15. Global Prostate Cancer Vaccines Sale Price by Application (2015-2020)
Table 16. Global Prostate Cancer Vaccines Sales by Company (2017-2019) (K Units)
Table 17. Global Prostate Cancer Vaccines Sales Market Share by Company (2017-2019)
Table 18. Global Prostate Cancer Vaccines Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Prostate Cancer Vaccines Revenue Market Share by Company (2017-2019)
Table 20. Global Prostate Cancer Vaccines Sale Price by Company (2017-2019)
Table 21. Global Prostate Cancer Vaccines Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Prostate Cancer Vaccines Products Offered
Table 23. Prostate Cancer Vaccines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Prostate Cancer Vaccines Consumption by Regions 2015-2020 (K Units)
Table 25. Global Prostate Cancer Vaccines Consumption Market Share by Regions 2015-2020
Table 26. Global Prostate Cancer Vaccines Value by Regions 2015-2020 ($ Millions)
Table 27. Global Prostate Cancer Vaccines Value Market Share by Regions 2015-2020
Table 28. Americas Prostate Cancer Vaccines Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Prostate Cancer Vaccines Consumption Market Share by Countries (2015-2020)
Table 30. Americas Prostate Cancer Vaccines Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Prostate Cancer Vaccines Value Market Share by Countries (2015-2020)
Table 32. Americas Prostate Cancer Vaccines Consumption by Type (2015-2020) (K Units)
Table 33. Americas Prostate Cancer Vaccines Consumption Market Share by Type (2015-2020)
Table 34. Americas Prostate Cancer Vaccines Consumption by Application (2015-2020) (K Units)
Table 35. Americas Prostate Cancer Vaccines Consumption Market Share by Application (2015-2020)
Table 36. APAC Prostate Cancer Vaccines Consumption by Countries (2015-2020) (K Units)
Table 37. APAC Prostate Cancer Vaccines Consumption Market Share by Countries (2015-2020)
Table 38. APAC Prostate Cancer Vaccines Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Prostate Cancer Vaccines Value Market Share by Regions (2015-2020)
Table 40. APAC Prostate Cancer Vaccines Consumption by Type (2015-2020) (K Units)
Table 41. APAC Prostate Cancer Vaccines Consumption Market Share by Type (2015-2020)
Table 42. APAC Prostate Cancer Vaccines Consumption by Application (2015-2020) (K Units)
Table 43. APAC Prostate Cancer Vaccines Consumption Market Share by Application (2015-2020)
Table 44. Europe Prostate Cancer Vaccines Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Prostate Cancer Vaccines Consumption Market Share by Countries (2015-2020)
Table 46. Europe Prostate Cancer Vaccines Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Prostate Cancer Vaccines Value Market Share by Countries (2015-2020)
Table 48. Europe Prostate Cancer Vaccines Consumption by Type (2015-2020) (K Units)
Table 49. Europe Prostate Cancer Vaccines Consumption Market Share by Type (2015-2020)
Table 50. Europe Prostate Cancer Vaccines Consumption by Application (2015-2020) (K Units)
Table 51. Europe Prostate Cancer Vaccines Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Prostate Cancer Vaccines Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Prostate Cancer Vaccines Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Prostate Cancer Vaccines Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Prostate Cancer Vaccines Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Prostate Cancer Vaccines Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Prostate Cancer Vaccines Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Prostate Cancer Vaccines Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Prostate Cancer Vaccines Consumption Market Share by Application (2015-2020)
Table 60. Prostate Cancer Vaccines Distributors List
Table 61. Prostate Cancer Vaccines Customer List
Table 62. Global Prostate Cancer Vaccines Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Prostate Cancer Vaccines Consumption Market Forecast by Regions
Table 64. Global Prostate Cancer Vaccines Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Prostate Cancer Vaccines Value Market Share Forecast by Regions
Table 66. Global Prostate Cancer Vaccines Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Prostate Cancer Vaccines Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Prostate Cancer Vaccines Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Prostate Cancer Vaccines Value Market Share Forecast by Type (2021-2025)
Table 70. Global Prostate Cancer Vaccines Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Prostate Cancer Vaccines Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Prostate Cancer Vaccines Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Prostate Cancer Vaccines Value Market Share Forecast by Application (2021-2025)
Table 74. Dendreon Corporation Product Offered
Table 75. Dendreon Corporation Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 76. Dendreon Corporation Main Business
Table 77. Dendreon Corporation Latest Developments
Table 78. Dendreon Corporation Basic Information, Company Total Revenue (in $ million), Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Inc. Product Offered
Table 80. Pfizer Inc. Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 81. Pfizer Inc. Main Business
Table 82. Pfizer Inc. Latest Developments
Table 83. Pfizer Inc. Basic Information, Company Total Revenue (in $ million), Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Bavarian Nordic Product Offered
Table 85. Bavarian Nordic Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 86. Bavarian Nordic Main Business
Table 87. Bavarian Nordic Latest Developments
Table 88. Bavarian Nordic Basic Information, Company Total Revenue (in $ million), Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. OncBioMune Pharmaceuticals Product Offered
Table 90. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 91. OncBioMune Pharmaceuticals Main Business
Table 92. OncBioMune Pharmaceuticals Latest Developments
Table 93. OncBioMune Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Advaxis immunotherapies Product Offered
Table 95. Advaxis immunotherapies Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 96. Advaxis immunotherapies Main Business
Table 97. Advaxis immunotherapies Latest Developments
Table 98. Advaxis immunotherapies Basic Information, Company Total Revenue (in $ million), Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Advantagene Product Offered
Table 100. Advantagene Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 101. Advantagene Main Business
Table 102. Advantagene Latest Developments
Table 103. Advantagene Basic Information, Company Total Revenue (in $ million), Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Curevac AG Product Offered
Table 105. Curevac AG Basic Information, Company Total Revenue (in $ million), Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. Curevac AG Main Business
Table 107. Curevac AG Latest Developments
Table 108. Curevac AG Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 109. SOTIO Product Offered
Table 110. SOTIO Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. SOTIO Main Business
Table 112. SOTIO Latest Developments
Table 113. SOTIO Basic Information, Company Total Revenue (in $ million), Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Mediolanum Farmaceutici Product Offered
Table 115. Mediolanum Farmaceutici Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 116. Mediolanum Farmaceutici Main Business
Table 117. Mediolanum Farmaceutici Latest Developments
Table 118. Mediolanum Farmaceutici Basic Information, Company Total Revenue (in $ million), Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Cleveland BioLabs Inc. Product Offered
Table 120. Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 121. Cleveland BioLabs Inc. Main Business
Table 122. Cleveland BioLabs Inc. Latest Developments
Table 123. Cleveland BioLabs Inc. Basic Information, Company Total Revenue (in $ million), Prostate Cancer Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. UbiVac Product Offered
Table 125. UbiVac Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 126. UbiVac Main Business
Table 127. UbiVac Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. UbiVac Latest Developments
Table 129. Vaccibody AS Product Offered
Table 130. Vaccibody AS Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 131. Vaccibody AS Main Business
Table 132. Vaccibody AS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Vaccibody AS Latest Developments
Table 134. Momotaro-Gene Inc. Product Offered
Table 135. Momotaro-Gene Inc. Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 136. Momotaro-Gene Inc. Main Business
Table 137. Momotaro-Gene Inc. Latest Developments
Table 138. Momotaro-Gene Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Vaccitech Product Offered
Table 140. Vaccitech Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 141. Vaccitech Main Business
Table 142. Vaccitech Latest Developments
Table 143. Vaccitech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. Ultimovacs Product Offered
Table 145. Ultimovacs Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 146. Ultimovacs Main Business
Table 147. Ultimovacs Latest Developments
Table 148. Ultimovacs Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Medigene AG Product Offered
Table 150. Medigene AG Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 151. Medigene AG Main Business
Table 152. Medigene AG Latest Developments
Table 153. Medigene AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Oncovir Inc. Product Offered
Table 155. Oncovir Inc. Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 156. Oncovir Inc. Main Business
Table 157. Oncovir Inc. Latest Developments
Table 158. Oncovir Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 159. Sensei Biotherapeutics Product Offered
Table 160. Sensei Biotherapeutics Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 161. Sensei Biotherapeutics Main Business
Table 162. Sensei Biotherapeutics Latest Developments
Table 163. Sensei Biotherapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 164. AlphaVax Inc. Product Offered
Table 165. AlphaVax Inc. Prostate Cancer Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 166. AlphaVax Inc. Main Business
Table 167. AlphaVax Inc. Latest Developments
Table 168. AlphaVax Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Prostate Cancer Vaccines
Figure 2. Prostate Cancer Vaccines Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Prostate Cancer Vaccines Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Prostate Cancer Vaccines Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Tablet
Figure 7. Product Picture of Injection
Figure 8. Global Prostate Cancer Vaccines Consumption Market Share by Type (2015-2020)
Figure 9. Global Prostate Cancer Vaccines Value Market Share by Type (2015-2020)
Figure 10. Prostate Cancer Vaccines Consumed in Hospital
Figure 11. Global Prostate Cancer Vaccines Market: Hospital (2015-2020) (K Units)
Figure 12. Global Prostate Cancer Vaccines Market: Hospital (2015-2020) ($ Millions)
Figure 13. Prostate Cancer Vaccines Consumed in Clinic
Figure 14. Global Prostate Cancer Vaccines Market: Clinic (2015-2020) (K Units)
Figure 15. Global Prostate Cancer Vaccines Market: Clinic (2015-2020) ($ Millions)
Figure 16. Prostate Cancer Vaccines Consumed in Others
Figure 17. Global Prostate Cancer Vaccines Market: Others (2015-2020) (K Units)
Figure 18. Global Prostate Cancer Vaccines Market: Others (2015-2020) ($ Millions)
Figure 19. Global Prostate Cancer Vaccines Consumption Market Share by Application (2015-2020)
Figure 20. Global Prostate Cancer Vaccines Value Market Share by Application (2015-2020)
Figure 21. Global Prostate Cancer Vaccines Sales Market Share by Company in 2017
Figure 22. Global Prostate Cancer Vaccines Sales Market Share by Company in 2019
Figure 23. Global Prostate Cancer Vaccines Revenue Market Share by Company in 2017
Figure 24. Global Prostate Cancer Vaccines Revenue Market Share by Company in 2019
Figure 25. Global Prostate Cancer Vaccines Sale Price by Company in 2019
Figure 26. Global Prostate Cancer Vaccines Consumption Market Share by Regions 2015-2020
Figure 27. Global Prostate Cancer Vaccines Value Market Share by Regions 2015-2020
Figure 28. Americas Prostate Cancer Vaccines Consumption 2015-2020 (K Units)
Figure 29. Americas Prostate Cancer Vaccines Value 2015-2020 ($ Millions)
Figure 30. APAC Prostate Cancer Vaccines Consumption 2015-2020 (K Units)
Figure 31. APAC Prostate Cancer Vaccines Value 2015-2020 ($ Millions)
Figure 32. Europe Prostate Cancer Vaccines Consumption 2015-2020 (K Units)
Figure 33. Europe Prostate Cancer Vaccines Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Prostate Cancer Vaccines Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Prostate Cancer Vaccines Value 2015-2020 ($ Millions)
Figure 36. Americas Prostate Cancer Vaccines Consumption Market Share by Countries in 2019
Figure 37. Americas Prostate Cancer Vaccines Value Market Share by Countries in 2019
Figure 38. Americas Prostate Cancer Vaccines Consumption Market Share by Type in 2019
Figure 39. Americas Prostate Cancer Vaccines Consumption Market Share by Application in 2019
Figure 40. United States Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 41. United States Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Prostate Cancer Vaccines Consumption Market Share by Countries in 2019
Figure 47. APAC Prostate Cancer Vaccines Value Market Share by Regions in 2019
Figure 48. APAC Prostate Cancer Vaccines Consumption Market Share by Type in 2019
Figure 49. APAC Prostate Cancer Vaccines Consumption Market Share by Application in 2019
Figure 50. China Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 51. China Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 58. India Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 59. India Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Prostate Cancer Vaccines Consumption Market Share by Countries in 2019
Figure 63. Europe Prostate Cancer Vaccines Value Market Share by Countries in 2019
Figure 64. Europe Prostate Cancer Vaccines Consumption Market Share by Type in 2019
Figure 65. Europe Prostate Cancer Vaccines Consumption Market Share by Application in 2019
Figure 66. Germany Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 68. France Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 69. France Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 70. UK Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 71. UK Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Prostate Cancer Vaccines Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Prostate Cancer Vaccines Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Prostate Cancer Vaccines Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Prostate Cancer Vaccines Consumption Market Share by Application in 2019
Figure 80. Egypt Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Prostate Cancer Vaccines Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Prostate Cancer Vaccines Value Growth 2015-2020 ($ Millions)
Figure 90. Global Prostate Cancer Vaccines Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Prostate Cancer Vaccines Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 93. Americas Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 94. APAC Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 95. APAC Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 96. Europe Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 97. Europe Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 100. United States Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 101. United States Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 102. Canada Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 103. Canada Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 104. Mexico Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 105. Mexico Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 106. Brazil Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 107. Brazil Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 108. China Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 109. China Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 110. Japan Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 111. Japan Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 112. Korea Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 113. Korea Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 116. India Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 117. India Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 118. Australia Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 119. Australia Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 120. Germany Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 121. Germany Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 122. France Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 123. France Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 124. UK Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 125. UK Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 126. Italy Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 127. Italy Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 128. Russia Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 129. Russia Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 130. Spain Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 131. Spain Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 132. Egypt Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 133. Egypt Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 134. South Africa Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 135. South Africa Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 136. Israel Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 137. Israel Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 138. Turkey Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 139. Turkey Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Prostate Cancer Vaccines Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Prostate Cancer Vaccines Value 2021-2025 ($ Millions)
Figure 142. Dendreon Corporation Prostate Cancer Vaccines Market Share (2018-2020)
Figure 143. Pfizer Inc. Prostate Cancer Vaccines Market Share (2018-2020)
Figure 144. Bavarian Nordic Prostate Cancer Vaccines Market Share (2018-2020)
Figure 145. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Market Share (2018-2020)
Figure 146. Advaxis immunotherapies Prostate Cancer Vaccines Market Share (2018-2020)
Figure 147. Advantagene Prostate Cancer Vaccines Market Share (2018-2020)
Figure 148. Curevac AG Prostate Cancer Vaccines Market Share (2018-2020)
Figure 149. SOTIO Prostate Cancer Vaccines Market Share (2018-2020)
Figure 150. Mediolanum Farmaceutici Prostate Cancer Vaccines Market Share (2018-2020)
Figure 151. Cleveland BioLabs Inc. Prostate Cancer Vaccines Market Share (2018-2020)
Figure 152. UbiVac Prostate Cancer Vaccines Market Share (2018-2020)
Figure 153. Vaccibody AS Prostate Cancer Vaccines Market Share (2018-2020)
Figure 154. Momotaro-Gene Inc. Prostate Cancer Vaccines Market Share (2018-2020)
Figure 155. Vaccitech Prostate Cancer Vaccines Market Share (2018-2020)
Figure 156. Ultimovacs Prostate Cancer Vaccines Market Share (2018-2020)
Figure 157. Medigene AG Prostate Cancer Vaccines Market Share (2018-2020)
Figure 158. Oncovir Inc. Prostate Cancer Vaccines Market Share (2018-2020)
Figure 159. Sensei Biotherapeutics Prostate Cancer Vaccines Market Share (2018-2020)
Figure 160. AlphaVax Inc. Prostate Cancer Vaccines Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets